Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07084181 · ClinicalTrials.gov registry record
Fitbit Assessed PS in Colorectal Cancer
A clinical trial, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT07084181 is a clinical trial that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 80 participants.
The verdict
NCT07084181 has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
Primary Objective To assess the feasibility of activity tracking using Fitbit device in terms of compliance (defined as at least 75% of patients complying with instructions to wear the device, for at least 12 hours a day on at least 3 of the 4 assigned days) in patients undergoing therapy for localized and advanced colorectal cancer. Secondary Objectives * To determine if physician-assessed performance status correlates with FitbitTM assessed physical activity (using active-minutes data). * To correlate baseline physical activity level as assessed by FitbitTM with incidence of grade III or higher toxicities experienced during treatment * To assess correlation between patient reported treatment related toxicities (PRO-CTCAE) and objective physical activity as measured by FitbitTM in patients treated for localized or metastatic cancers treated with chemotherapy * To correlate baseline and interval change in physical activity levels as assessed by FitbitTM with post-surgical outcomes including inpatient length of stay, perioperative complications, post-operative 30-day mortality, and time to adjuvant treatment initiation (in days)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2019-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07084181
The ClinicalTrials.gov registry entry for NCT07084181 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07084181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07084181 about?
NCT07084181 is a clinical study titled "Fitbit Assessed PS in Colorectal Cancer". Primary Objective To assess the feasibility of activity tracking using Fitbit device in terms of compliance (defined as at least 75% of patients complying with instructions to wear the device, for at least 12 hours a day on at least 3 of the 4 assigned days) in patients undergoing therapy for local...
What is the current status of trial NCT07084181?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2017-02-15. Estimated completion is 2019-07-22.
Who is sponsoring clinical trial NCT07084181?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.